Association of digoxin with mortality in patients with advanced chronic kidney disease: A population-based cohort study

Digoxin is commonly prescribed for heart failure and atrial fibrillation, but there is limited data on its safety in patients with chronic kidney disease (CKD). We conducted a population-based cohort study using the pre-end stage renal disease (ESRD) care program registry and the National Health Ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lii-Jia, Hsu, Shan-Min, Wu, Ping-Hsun, Lin, Ming-Yen, Huang, Teng-Hui, Lin, Yi-Ting, Kuo, Hung-Tien, Chiu, Yi-Wen, Hwang, Shang-Jyh, Tsai, Jer-Chia, Chen, Hung-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810292/
https://www.ncbi.nlm.nih.gov/pubmed/33449946
http://dx.doi.org/10.1371/journal.pone.0245620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810292/
https://www.ncbi.nlm.nih.gov/pubmed/33449946
http://dx.doi.org/10.1371/journal.pone.0245620

Ejemplares similares